Vanda Pharmaceuticals (VNDA) Other financing activities (2010 - 2018)

Vanda Pharmaceuticals' Other financing activities history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2018.

• In Q1 2018, Other financing activities rose 20.69% year-over-year to $2.7 million; the TTM figure through Mar 2018 stood at $5.7 million (down 42.55% YoY), while the FY2017 annual figure was $5.3 million, down 32.25% from the prior year.
• Other financing activities came in at $2.7 million for Q1 2018 at Vanda Pharmaceuticals, up from $81000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $5.9 million in Q3 2016 to a low of -$2.2 million in Q4 2014.
• A 5-year average of $1.2 million and a median of $750000.0 in 2016 frame the typical range for Other financing activities.
• On a YoY basis, Other financing activities climbed as much as 122300.0% in 2014 and fell as far as 559.43% in 2014.
• Vanda Pharmaceuticals' Other financing activities stood at -$2.2 million in 2014, then surged by 282.52% to $4.1 million in 2015, then tumbled by 81.67% to $750000.0 in 2016, then tumbled by 89.2% to $81000.0 in 2017, then jumped by 3191.36% to $2.7 million in 2018.
• According to Business Quant data, Other financing activities over the past three periods registered $2.7 million, $81000.0, and $768000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.

Peer Comparison